A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1994
12/22/1994	WO1994029330A1 Myeloid cell leukemia associated gene mcl-1
12/22/1994	WO1994028949A1 Biological adhesive composition and method of promoting adhesion between tissue surfaces
12/22/1994	WO1994028938A1 Adenovirus vectors for gene therapy sponsorship
12/22/1994	WO1994028935A1 Methods and compositions for aiding periodontal tissue regeneration
12/22/1994	WO1994028934A1 Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies
12/22/1994	WO1994028933A1 Bispecific human monoclonal antibodies specific for human immunodeficiency virus
12/22/1994	WO1994028932A1 Immunoglobulin infusion in xenotransplantation
12/22/1994	WO1994028931A1 Methods for treating inflammatory disorders
12/22/1994	WO1994028930A1 Malaria recombinant poxvirus vaccine
12/22/1994	WO1994028926A1 Interleukin-2 stimulated t lymphocyte cell death for the treatment of autoimmune diseases, allergic disorders, and graft rejection
12/22/1994	WO1994028923A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
12/22/1994	WO1994028922A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype
12/22/1994	WO1994028921A1 Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
12/22/1994	WO1994028920A1 Synthetic peptide inhibitors of hiv transmission
12/22/1994	WO1994028919A1 Hematopoietic cell proliferation accelerator
12/22/1994	WO1994028918A1 Vaginal preparation containing physiologically active peptide
12/22/1994	WO1994028917A1 Pharmaceutical formulations
12/22/1994	WO1994028916A1 Release and mobilisation of haematopoietic cells
12/22/1994	WO1994028915A1 Hiv retrovirus infection inhibitor capable of interacting with cd26 receptor
12/22/1994	WO1994028914A1 Assay and reagents for identifying anti-proliferative agents
12/22/1994	WO1994028913A1 Methods and pharmaceutical compositions useful for treating neurological disorders
12/22/1994	WO1994028912A1 Cd28 pathway immunosuppression
12/22/1994	WO1994028911A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
12/22/1994	WO1994028889A1 Purified natural and synthetic compounds for the treatment of osteoarthritis
12/22/1994	WO1994028884A1 Zinc monoglycerolate complex for anti-rejection treatment of the human or animal body
12/22/1994	WO1994028726A2 Method of treating retained pulmonary secretions
12/22/1994	WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	WO1994028720A1 Oligomers for modulating ras oncogene
12/22/1994	WO1994025477A3 Novel peptide nucleic acids
12/22/1994	WO1994025056A3 Use of platelet-derived growth factor to improve collateral circulation
12/22/1994	WO1994024154A3 Immuno modulated peptide derivatives of leukokinin fragments
12/22/1994	WO1994022483A3 Prodrugs with enhanced penetration into cells
12/22/1994	WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
12/22/1994	WO1994016085A3 Hybrid proteins having cross-linking and tissue-binding activities
12/22/1994	WO1994016075A3 Process for producing m-csf 223
12/22/1994	WO1994016074A3 High molecular weight b-cell growth factor: interleukin-14
12/22/1994	DE4401419C1 Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms
12/22/1994	DE4345200A1 Pharmaceutical composition for the treatment of immune reactions
12/22/1994	DE4320315A1 Use of a casein-containing propolis extract
12/22/1994	CA2168124A1 Malaria recombinant poxvirus vaccine
12/22/1994	CA2164953A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives
12/22/1994	CA2164880A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues
12/22/1994	CA2164811A1 Super proteins including interferons and interleukins
12/22/1994	CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	CA2164623A1 Hybrid receptor molecules
12/22/1994	CA2164606A1 Compositions for use in the regulation of subnormal ph values in the intestinal tract and for treatment of bowel diseases
12/22/1994	CA2164518A1 Immunoreactive reagents employing monoamine oxidase
12/22/1994	CA2164295A1 Human-derived tumor cell growth inhibitors
12/22/1994	CA2163905A1 Inhibiting protein interactions
12/22/1994	CA2163345A1 Antibodies
12/22/1994	CA2163344A1 Humanised antibodies
12/22/1994	CA2163250A1 Biological adhesive composition and method of promoting adhesion between tissue surfaces
12/22/1994	CA2163011A1 New peptides derivatives
12/22/1994	CA2161349A1 Immunoglobulin infusion in xenotransplantation
12/22/1994	CA2142621A1 Paper strengthened with solubilized collagen, and method for making the same
12/21/1994	EP0629703A2 Monoclonal antibodies to Fc receptors for immunoglobulin G on human mono-nuclear phagocytes, bifunctional antibodies, target specific effector cells, targeted macrophages, and innunoassays
12/21/1994	EP0629636A1 Lipopeptides from actinoplanes sp. endowed with pharmacological activity, process for their preparation and their use
12/21/1994	EP0629627A2 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors
12/21/1994	EP0629408A1 Combination of angiotensin converting enzyme inhibitors and AII antagonists
12/21/1994	EP0629407A2 Use of human protein C for prevention and treatment of depositions of thrombocytes
12/21/1994	EP0629406A1 Medicament for the treatment of sepsis or septic shock
12/21/1994	EP0629393A2 A crystalline polyol composition
12/21/1994	EP0629350A1 Milk protein hydrolysates
12/21/1994	EP0629347A1 Antibacterial agent and treatment of article therewith
12/21/1994	EP0629293A1 Assay for adrenal autoantigen
12/21/1994	EP0629244A1 Pathogen-targeted biocatalyst.
12/21/1994	EP0629240A1 Altered antibodies, products and processes relating thereto
12/21/1994	EP0629238A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
12/21/1994	EP0629213A1 Immunostimulatory agent.
12/21/1994	EP0629211A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
12/21/1994	EP0629210A1 Peptide linkage unit comprising methylene phosphinic acid
12/21/1994	EP0629133A1 Protein- and peptide-metal ion pharmaceutical applications
12/21/1994	EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME
12/21/1994	EP0629130A1 Use of interleukin-10 to suppress graft-vs.-host disease
12/21/1994	EP0629129A1 Method for kidney tubulogenesis
12/21/1994	EP0579763A4 Novel peptide compositions and uses therefor.
12/21/1994	EP0489836B1 Light activated acyl-enzymes
12/21/1994	EP0424518B1 Utilisation of adenyl cyclase as vaccine against bordetella
12/21/1994	EP0220273B1 Synthetic antigens for the detection of aids-related disease
12/21/1994	CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said.........
12/21/1994	CN1096541A Recombination of human macrophage colony stimulating factor by domestic silkworm gene engineering
12/21/1994	CN1096516A Improved meningococoal polysaccharide conjugate vaccine
12/21/1994	CN1096515A New peptides
12/20/1994	US5374714 Purified coriolus versicolor polypeptide complex
12/20/1994	US5374713 Peptide inhibitors of phospholipase A2 purified from inflammatory sites
12/20/1994	US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them
12/20/1994	US5374651 Hypertensive agents; inhibit nitric oxide production
12/20/1994	US5374643 Antiischemic agents
12/20/1994	US5374623 Cysteine protease inhibitors effective for in vivo use
12/20/1994	US5374622 Fibrinogen receptor antagonists
12/20/1994	US5374621 Neurotensin method for inhibiting vascular leakage
12/20/1994	US5374620 Growth-promoting composition and its use
12/20/1994	US5374618 Calcitonin peptides, and gene related pharmaceutical compositions
12/20/1994	US5374617 Treatment of bleeding with modified tissue factor in combination with FVIIa
12/20/1994	US5374616 Compositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factor
12/20/1994	US5374550 Thyroid-derived chondrocyte-stimulating factor
12/20/1994	US5374549 Treating tumors; culturing with suppression of expansion of adherent lymphokine-activated killer(A-LAK) cells
12/20/1994	US5374548 Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
12/20/1994	US5374529 Methods of and compositions for diagnosis, monitoring and treating the early stages of osteoarthritis
12/20/1994	US5374506 Amino acid sequence for a functional human interleukin-8 receptor

1 ... 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 ... 3163